Daclatasvir Plus Sofosbuvir Plus Ribavirin for 12 or 16 Weeks in Treatment-Experienced Patients With HCV Genotype 3 Infection and Advanced Fibrosis or Cirrhosis

被引：0
作者：
Hezode, Christophe
Dore, Gregory J.
Pianko, Stephen
Pol, Stanislas
Stuart, Katherine
Thompson, Alexander
Tse, Edmund
Bhore, Rafia
Jimenez-Exposito, Maria Jesus
机构：
来源：
GASTROENTEROLOGY | 2016年 / 150卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(16)33701-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1424
引用
收藏
页码：S1096 / S1096
页数：1
相关论文
共 50 条
[21]   THE IMPROVEMENT OR REGRESSION OF FIBROSIS AFTER TREATMENT WITH SOFOSBUVIR PLUS RIBAVIRIN FOR HCV GENOTYPE 2 INFECTION [J].
Jung, Young Kul ;
Kim, Taehyung ;
Yim, Hyung-Joon ;
Lee, Han Ah ;
Young, Yim Sun ;
Seo, Yeon Seok ;
Um, Soon Ho ;
Lee, Young-Sun ;
Kim, Ji Hoon ;
Yeon, Jong Eun ;
Byun, Kwan Soo .
HEPATOLOGY, 2020, 72 :575A-576A
[22]   Simeprevir plus sofosbuvir for eight or 12 weeks in treatment-naive and treatment-experienced hepatitis C virus genotype 4 patients with or without cirrhosis [J].
El Raziky, M. ;
Gamil, M. ;
Ashour, M. K. ;
Sameea, E. A. ;
Doss, W. ;
Hamada, Y. ;
Van Dooren, G. ;
DeMasi, R. ;
Keim, S. ;
Lonjon-Domanec, I. ;
Hammad, R. ;
Hashim, M. S. ;
Hassany, M. ;
Waked, I. .
JOURNAL OF VIRAL HEPATITIS, 2017, 24 (02) :102-110
[23]   Sofosbuvir plus Ribavirin in the Treatment of Egyptian Patients with Chronic Genotype 4 HCV Infection [J].
Esmat, Gamal E. ;
Shiha, Gamal ;
Omar, Rabab F. ;
Hassany, Mohamad ;
Hammad, Radi ;
Khairy, Marwa ;
Samir, Waleed ;
Soliman, Reham ;
Brainard, Diana M. ;
Jiang, Deyuan ;
Kersey, Kathryn ;
Knox, Steven J. ;
Massetto, Benedetta ;
McHutchison, John G. ;
Doss, Wahid H. .
HEPATOLOGY, 2014, 60 :662A-663A
[24]   Sofosbuvir plus Ribavirin in the Treatment of Egyptian Patients with Chronic Genotype 4 HCV Infection [J].
Doss, Wahid H. ;
Ruane, Peter J. ;
Shiha, Gamal ;
Ain, Dani ;
Soliman, Reham ;
Khairy, Marwa ;
Hassany, Mohamad ;
Riad, Joseph ;
Samir, Waleed ;
Omar, Rabab F. ;
Hammad, Radi ;
Meshrekey, Raymond ;
Gamil, Mostafa ;
Jiang, Deyuan ;
Massetto, Benedetta ;
Knox, Steven J. ;
Kersey, Kathryn ;
McHutchison, John G. ;
Esmat, Gamal E. .
HEPATOLOGY, 2015, 62 :737A-738A
[25]   12 weeks of sofosbuvir, daclatasvir and ribavirin for GT3 patients with cirrhosis [J].
Troland, D. ;
Fox, R. ;
Morris, J. ;
Priest, M. ;
Heydtmann, M. ;
Barclay, S. T. .
JOURNAL OF HEPATOLOGY, 2017, 66 (01) :S304-S304
[26]   EFFECT OF RIBAVIRIN ON THE SAFETY PROFILE OF DACLATASVIR plus SOFOSBUVIR FOR PATIENTS WITH CHRONIC HCV INFECTION [J].
Sulkowski, M. ;
Gardiner, D. ;
Hughes, E. ;
Huang, S. -P. ;
Grasela, D. .
JOURNAL OF HEPATOLOGY, 2014, 60 (01) :S471-S471
[27]   A Bayesian Bridging Model Using Phase 3 Data in Treatment-Experienced HCV Genotype 3 Patients Demonstrates Extending Sofosbuvir plus Ribavirin Treatment from 12 to 16 Weeks in Treatment-Naive Genotype 3 Patients May Significantly Increase SVR Rates [J].
Bekele, B. Nebiyou ;
Nelson, David R. ;
Gordon, Stuart C. ;
Feld, Jordan J. ;
Patel, Keyur ;
Lawitz, Eric ;
Sheikh, Aasim M. ;
Brainard, Diana M. ;
Symonds, William T. ;
McHutchison, John G. ;
Mangia, Alessandra ;
Gane, Edward J. .
HEPATOLOGY, 2013, 58 :754A-754A
[28]   Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-Alfa in Patients With Hepatitis C Virus Genotype 3 Infection and Treatment-Experienced Patients With Cirrhosis and Hepatitis C Virus Genotype 2 Infection [J].
Foster, Graham R. ;
Pianko, Stephen ;
Brown, Ashley ;
Forton, Daniel ;
Nahass, Ronald G. ;
George, Jacob ;
Barnes, Eleanor ;
Brainard, Diana M. ;
Massetto, Benedetta ;
Lin, Ming ;
Han, Bin ;
McHutchison, John G. ;
Subramanian, G. Mani ;
Cooper, Curtis ;
Agarwal, Kosh .
GASTROENTEROLOGY, 2015, 149 (06) :1462-1470
[29]   High Efficacy of Treatment with Sofosbuvir+GS-5816 ±Ribavirin for 12 Weeks in Treatment Experienced Patients with Genotype 1 or 3 HCV Infection [J].
Pianko, Stephen ;
Flamm, Steven L. ;
Shiffman, Mitchell L. ;
Kumar, Sonal ;
Strasser, Simone I. ;
Dore, Gregory J. ;
McNally, John ;
Brainard, Diana M. ;
Han, Lingling ;
Doehle, Brian ;
Mogalian, Erik ;
McHutchison, John G. ;
Reddy, K. Rajender ;
Roberts, Stuart K. .
HEPATOLOGY, 2014, 60 :297A-298A
[30]   RESISTANCE ANALYSIS OF TREATMENT-EXPERIENCED GENOTYPE 1 AND 3 HCV INFECTED PATIENTS TREATED WITH SOFOSBUVIR IN COMBINATION WITH GS-5816+/- RIBAVIRIN FOR 12 WEEKS [J].
Doehle, B. P. ;
Svarovskaia, E. S. ;
Chodavarapu, K. ;
McNally, J. ;
Pianko, S. ;
Roberts, S. K. ;
Brainard, D. M. ;
Miller, M. D. ;
Mo, H. .
JOURNAL OF HEPATOLOGY, 2015, 62 :S678-S678
12345